…with the FDA giving Orphan Drug Status, it's pretty clear they are on board too.
An FDA Orphan Designation is all but assured when a drug candidate addresses a US market of fewer than 200,000 patients—it is not an FDA vote of confidence in the drug.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”